Amgen vs. Gilead Sciences: Which Biotech Dividend Stock Is the Better Buy?
Both of these biotech stocks could be appealing to income investors.
·
The Motley Fool
Prediction: This Is Where Palantir Stock Will Trade When Its Revenue Hits $10 Billion
The AI software specialist is nearing a $10 billion year. Will its share price rise with its sales?
·
The Motley Fool
Alphabet’s 2 Classes of Common Stock Trade About 1% Apart. Here’s the One I’d Buy.
One class has a vote. Is that vote worth paying about 1% more for?
·
The Motley Fool
The Unwanted Surprise Lurking Behind 2027’s Social Security COLA
There's a downside to a generous raise.
·
The Motley Fool
This Stock Market Metric Warns History May Be Repeating Itself. Here’s How the Smartest Investors Are Preparing.
A bear market could be on the way, but the right strategy can protect your portfolio.
·
The Motley Fool
Got $1,000? This Nuclear Fuel Stock Is the Pick-and-Shovel Play I’d Buy Right Now.
Centrus Energy is the lone publicly traded U.S.-based uranium enricher.
·
The Motley Fool
GM Just Announced a $20 Billion Buyback. Tesla Trades at 350 Times Earnings. Here’s Which Auto Stock I’d Buy Today.
Both automakers offer something different for potential investors.
·
The Motley Fool
